Increased oral bioavailability of ciprofloxacin in cystic fibrosis patients.

Increased oral bioavailability of ciprofloxacin in cystic fibrosis patients.

Item
http://www.wikidata.org/entity/Q40284573
Intravenous antibiotics for pulmonary exacerbations in people with cystic fibrosisOral anti-pseudomonal antibiotics for cystic fibrosisOral anti-pseudomonal antibiotics for cystic fibrosisOral anti-pseudomonal antibiotics for cystic fibrosisFluoroquinolones in the treatment of bronchopulmonary disease in cystic fibrosisConsiderations for a Pediatric Biopharmaceutics Classification System (BCS): application to five drugs.Population pharmacokinetics and use of Monte Carlo simulation to evaluate currently recommended dosing regimens of ciprofloxacin in adult patients with cystic fibrosisOptimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: III. fluoroquinolones.Uncertainty and variability in human exposure limits - a chemical-specific approach for ciprofloxacin and methotrexate.Suboptimal ciprofloxacin dosing as a potential cause of decreased Pseudomonas aeruginosa susceptibility in children with cystic fibrosis.
P2860

Increased oral bioavailability of ciprofloxacin in cystic fibrosis patients.

Item
http://www.wikidata.org/entity/Q40284573
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Increased oral bioavailability of ciprofloxacin in cystic fibrosis patients.
@en
type
label
Increased oral bioavailability of ciprofloxacin in cystic fibrosis patients.
@en
prefLabel
Increased oral bioavailability of ciprofloxacin in cystic fibrosis patients.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Increased oral bioavailability of ciprofloxacin in cystic fibrosis patients.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932